Skip to main content

Find Clinical Trials

Home
Conditions
Peripheral Nervous System Neoplasms

Clinical trial condition

Peripheral Nervous System Neoplasms

Explore clinical trials studying Peripheral Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

257 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Peripheral Nervous System Neoplasms trial results

Completed

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

NCT00068367

Conditions: Fibrosarcoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

University of California Davis Cancer Center Davis, California, United States

Contra Costa Regional Medical Center Martinez, California, United States

St. Anthony Central Hospital Denver, Colorado, United States

View all 101 locations

View Trial Details

Completed

Study of PEG-Intron for Plexiform Neurofibromas

NCT00396019

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, +9 more
Locations: Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

NCT01140360

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: Riley Hospital for Children Indianapolis, Indiana, United States

View Trial Details

Completed

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

NCT00112463

Conditions: Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, +59 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients

NCT01490476

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Hôpital Beaujon, 100 boulevard du Général Leclerc Clichy, France

View Trial Details

Completed

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

NCT01275586

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Riley Hospital for Children Indianapolis, Indiana, United States

View Trial Details

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT02104323

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

NCT00450736

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone, Chondrosarcoma, Fibrosarcoma, +25 more
Locations: University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States

View Trial Details

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma

NCT02963896

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +19 more
Locations: Not specified

View Trial Details